PDS Biotechnology Corp
NASDAQ:PDSB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
US |
|
Golden Agri-Resources Ltd
SGX:E5H
|
SG |
|
Ormat Technologies Inc
NYSE:ORA
|
US |
|
MTAR Technologies Ltd
NSE:MTARTECH
|
IN |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Red River Bancshares Inc
NASDAQ:RRBI
|
US |
|
WiseTech Global Ltd
ASX:WTC
|
AU |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
Man Group PLC
LSE:EMG
|
UK |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
Alaska Air Group Inc
NYSE:ALK
|
US |
|
Abionyx Pharma SA
PAR:ABNX
|
FR |
|
Eagle Eye Solutions Group PLC
LSE:EYE
|
UK |
|
Fomento Economico Mexicano SAB de CV
NYSE:FMX
|
MX |
|
Fission Uranium Corp
TSX:FCU
|
CA |
|
Monster Beverage Corp
NASDAQ:MNST
|
US |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
Elixirr International PLC
LSE:ELIX
|
UK |
|
Alps Alpine Co Ltd
TSE:6770
|
JP |
Wall St Price Targets
PDSB Price Targets Summary
PDS Biotechnology Corp
According to Wall Street analysts, the average 1-year price target for
PDSB is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 15.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PDSB's stock price target?
Price Target
7.65
USD
According to Wall Street analysts, the average 1-year price target for
PDSB is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 15.75 USD.